Stepan (SCL) Stock Dropped, So What Is Behind The Latest Move?

What Stepan’s New Credit Agreement Means For Investors

Stepan (SCL) has reset its lending arrangements with a fresh US$500 million credit agreement that includes a US$350 million multicurrency revolver and a US$150 million delayed draw term loan.

The facilities run to 2031 and can support working capital, acquisitions, capital projects, and general corporate spending, giving the chemicals producer updated financial flexibility following the replacement of its prior credit lines.

Recent trading has been choppy for Stepan, with the share price down 2.71% over the past day and 3.40% over the last week. However, the 90-day share price return of 11.43% and year-to-date share price gain of 31.87% point to improving momentum, while the 5-year total shareholder return, down 40.89%, shows that longer term holders have had a much tougher run.

Spot 17 high quality undiscovered gems that, like Stepan with its refreshed US$500 million credit capacity, are quietly reshaping their balance sheets ahead of their next phase.

Stepan now has fresh lending firepower and a long operating history in chemicals, yet the stock still carries a mixed return record and a recent reset in credit. So what are investors actually paying for that profile today?

Most Popular Narrative: 27% Undervalued

On the most followed narrative, Stepan’s fair value sits at $85 per share versus the last close of $62.19. This frames the new credit agreement against a stock that is priced below that narrative estimate.

The startup of the new Pasadena, Texas site is expected to reach full contribution in the second half of 2025, which could boost volume growth and supply chain savings. This is likely to impact revenue and margins positively.

See why 6 investors see Stepan as 27% undervalued.

Result: Fair Value of $85 (UNDERVALUED)

Still, the story can break if higher interest rates keep rigid polyol demand subdued, or if raw material costs in Surfactants squeeze Stepan’s profitability harder than expected.

Find out about the key risks to this Stepan narrative.

Next Steps

Mixed signals around Stepan’s credit reset and valuation can spark debate, so review the data for yourself, move quickly, and weigh up the 3 key rewards and 2 important warning signs.

Ready For More Stepan-Like Ideas?

If Stepan’s reset credit position has you thinking about where capital might work harder next, do not stop at a single ticker. A broader watchlist built from focused screeners can reveal companies with different risk profiles and income characteristics, so use these curated sets as a fast way to surface ideas that match your goals.

• Target potential value opportunities by scanning companies that combine quality fundamentals with discounted pricing through the 32 high quality undervalued stocks.
• Strengthen your income stream by filtering for resilient payers with higher yields using the 6 dividend fortresses.
• Dial down portfolio stress by zeroing in on businesses with sturdier finances via the 32 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com